 Patients undergo blood sample collection periodically to determine markers of bone formation and resorption by ELISA; parathyroid hormone PTH levels by immunometric assay; prostate-specific antigen PSA levels by immunoassay; and 25-hydroxyvitamin D and 1,25OH_2D levels by radioimmunoassay. 